Literature DB >> 17101412

Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy.

Youko Idobe-Fujii1, Nagako Ogi, Keiko Hosho, Masahiko Koda, Yoshikazu Murawaki, Yasushi Horie.   

Abstract

A patient was diagnosed with chronic hepatitis C at the age of 63 years. He achieved eradication of HCV via interferon (IFN). Eight years after, a hepatocellular carcinoma (HCC) was detected and treated through transarterial embolization and percutaneous ethanol injection therapy. After about 1 year, a large hypovascular tumor was detected. This tumor was surgically resected and diagnosed as an HCC with sarcomatous change. This is the first case of an HCC with sarcomatous change arising after a sustained response to IFN therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101412     DOI: 10.1016/j.clinimag.2006.07.004

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  2 in total

1.  Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation.

Authors:  Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Chul-Soo Ahn; Ki-Hun Kim; Kwang-Min Park; Ki-Myung Moon; Deok-Bog Moon; Tae-Yong Ha; Eun-Sil Yu; Ga-Won Choi
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

2.  Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.

Authors:  Ken Kurokawa; Takamasa Ohki; Jun Kato; Yukiyo Fukumura; Makoto Imai; Chikako Shibata; Junya Arai; Mayuko Kondo; Kaoru Takagi; Kentaro Kojima; Michiharu Seki; Masaya Mori; Nobuo Toda; Kazumi Tagawa
Journal:  J Med Case Rep       Date:  2020-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.